-- 
Arseus, Heineken, HES Beheer, ING: Benelux Equity Preview

-- B y   M a u d   v a n   G a a l   a n d   J o h n   M a r t e n s
-- 
2011-02-16T05:00:01Z

-- http://www.bloomberg.com/news/2011-02-15/arseus-heineken-hes-beheer-ing-benelux-equity-preview.html
The following companies may have
unusual price changes in Benelux markets. Stock symbols are in
parentheses, and prices are from the previous close.  The  AEX-Index  in Amsterdam rose 0.34, or 0.1 percent, to
370.51. Belgium’s Bel20 Index gained 0.2 percent to 2,730.78.
The  Luxembourg LuxX Index  increased less than 0.1 percent to
1,513.94.  Dutch stocks:    Heineken NV  (HEIA NA): The world’s third-largest brewer may
say full-year net income rose to 1.33 billion euros ($1.8
billion), according to the average of 18 analyst estimates
compiled by Bloomberg, from 1.02 billion euros a year earlier.
Heineken climbed 1.6 percent to 36.89 euros.  HES Beheer NV (HES NA): The Dutch provider of port services
said 2010 net income rose 31 percent to 21.9 million euros,
based on preliminary figures. HES Beheer increased 0.3 percent
to 33.45 euros.    ING Groep NV  (INGA NA): The biggest Dutch financial-
services company may report fourth-quarter net income of 537.1
million euros, the average estimate of 12 analysts surveyed by
Bloomberg. ING dropped 0.3 percent to 8.98 euros.  Belgian stocks:  Aedifica SA (AED BB): Belgium’s biggest residential real-
estate investment fund said fiscal first-half profit excluding
some items fell to 87 cents a share from 93 cents a year earlier
and maintained its forecast for a final dividend of 1.16 euros a
share.  Aedifica  advanced 0.5 percent to 42.10 euros.    Arseus NV  (RCUS BB): Europe’s biggest supplier of
ingredients to compounding pharmacies may say full-year net
income rose to 24.2 million euros, the average of seven analyst
estimates compiled by Bloomberg, from 19.6 million euros in
2009. Arseus gained 1.2 percent to 11.43 euros.  To contact the reporters on this story:
Maud van Gaal in Amsterdam at 
 mvangaal@bloomberg.net ;
John Martens in Brussels at 
 jmartens1@bloomberg.net .  To contact the editors responsible for this story:
Frank Connelly at   fconnelly@bloomberg.net ;
Angela Cullen at   acullen8@bloomberg.net . 